Phytochemistry, pharmacology and toxicology of Peganum harmala

Authors

  • Chengling Liu School of Chemical Engineering and Pharmaceutics, Henan University of Science and Technology, Luoyang, China.
  • Jiayu Gao School of Chemical Engineering and Pharmaceutics, Henan University of Science and Technology, Luoyang, China.
  • Ying Liang Institute of Mental Health, Peking University, Beijing, China.

DOI:

https://doi.org/10.3329/bjp.v17i4.61326

Keywords:

Alkaloid, Anti-cancer, Antimicrobial, Peganum harmala, Toxicology

Abstract

This systematic review focuses on the phytochemical, pharmacological and toxicological aspects of P. harmala, which aims to construct the scientific foundations of P. harmala-based drugs. Until now, over 390 secondary metabolites, including alkaloids, flavonoids, triterpenoids, phenolic acids, anthraquinones, fatty acids, and essential oils, had been identified from different parts of P. harmala. The plant and its important bioactive compounds demonstrated various pharmacological activities, mainly including antimicrobes, anti-cancer, anti-atherogenesis, anti-diabetes, anti-inflammation, neuropsychological, analgesic, hepatoprotective, bronchodilating, gastroprotective, diuretic, and hypothermic effects. However, excessive use of high doses of P. harmala extract could lead to serious hepatic, nephritic, and neuropathic toxicities. Current evidence validates the claimed effectiveness of traditional uses of P. harmala for many symptoms.

Downloads

Download data is not yet available.
Abstract
41
Download
33 Supplementary Table I
15 Supplementary Table II
13 Supplementary Table III
10

References

Abbas MW, Hussain M, Qamar M, Ali S, Shafiq Z, Wilairatana P, Mubarak MS. Antioxidant and anti-inflammatory effects of Peganum harmala extracts: An in vitro and in vivo study. Molecules 2021; 26: 6084.

Abderrahim AL, Taïbi K, Ait Abderrahim C. Assessment of the antimicrobial and antioxidant activities of Ziziphus lotus and Peganum harmala. ISTT. 2019; 43: 409-14.

Achour S, Rhalem N, Khattabi A, Lofti H, Mokhtari A, Soulaymani A, Turcant A, Bencheikh RS. L’intoxication au Peganum harmala L. au Maroc: A propos de 200 cas. Thérapie. 2012; 67: 53-58.

Adhami H, Farsam H, Krenn L. Screening of medicinal plants from Iranian traditional medicine for Acetylcholinesterase inhibition. Phytother Res. 2011; 25: 1148-52.

Afzal M, Shahid M, Jamil A, Rehman SU. Phytochemical spectrum of essential oil of Paganum harmala by GC-MS and antimicrobial activity using sequential solvents fractions and essential oil. Asian J Chem. 2014; 26: 574-78.

Ahmad M, Ashraf M, Khan MS, Javeed A, Durrani AZ, Altaf I, Ijaz M, Malik NA. Toxic effects of chloroform and aqueous extracts of Peganum harmala on hematological and growth parameters in rabbits. Pak J Zool. 2013; 45(4): 989-995.

Ahmed H, Elzahab HA, Alswiai G. Purification of antioxidant protein isolated from Peganum harmala and its protective effect against CCl4 toxicity in rats. Turk J Biol. 2013; 37: 39-48.

Akhtar MF, Raza SA, Saleem A, Hamid I, Ashraf Baig MMF, Sharif A, Sohail K, Javaid Z, Saleem U, Rasul A. Appraisal of anti-arthritic and anti-inflammatory potential of folkloric medicinal plant Peganum harmala. Endocr Metab Immune. 2022; 22: 49-63.

Al-Saikhan FI, Ansari MN. Evaluation of the diuretic and uri-nary electrolyte effects of methanolic extract of Peganum harmala L. in Wistar albino rats. Saudi J Biol Sci. 2016; 23: 749-53.

Ali G, Cyrus J, Mohammad Reza S, Setareh J, Saeed R, Nasim A. Harmine mitigates cisplatin-induced renal injury in male mice through antioxidant, anti-inflammatory, and anti-apoptosis effects. Res Pharm Sci. 2022; 17: 417-27.

Ali SK, Hamed AR, Soltan MM, Hegazy UM, Elgorashi EE, El-Garf IA, Hussein AA. In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease. BMC Complem Altern M. 2013; 13: 1-10.

Apostolico L, Aliberti L, Caputo L, De Feo V, Fratianni F, Nazzaro F, Souza LF, Khadhr M. Chemical composition, antibacterial and phytotoxic activities of Peganum harmala seed essential oils from five different localities in Northern Africa. Molecules 2016; 21: 1235.

Arshad N, Zitterl-Eglseer K, Hasnain S, Hess M. Effect of Peganum harmala or its β-carboline alkaloids on certain antibiotic resistant strains of bacteria and protozoa from poultry. Phytother Res. 2008; 22: 1533-38.

Asgarpanah J, Ramezanloo F. Chemistry, pharmacology and medicinal properties of Peganum harmala L. Afr J Pharm Pharmaco. 2012; 6: 1573-80.

Astulla A, Zaima K, Matsuno Y, Hirasawa Y, Ekasari W, Widyawaruyanti A, Zaini NC, Morita H. Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities. J Nat Med-Tokyo. 2008; 62: 470-72.

Ayoob I, Hazari YM, Lone SH, Khuroo MA, Fazili KM, Bhat KA. Phytochemical and cytotoxic evaluation of Peganum harmala: Structure activity relationship studies of harmine. ChemistrySelect. 2017; 2: 2965-68.

Bensalem S, Soubhye J, Aldib I, Bournine L, Nguyen AT, Vanhaeverbeek M, Rousseau A, Boudjeltia KZ, Sarakbi A, Kauffmann MJ, Nève J, Prévostf M, Stévigny C, Maiza-Benabdesselam F, Bedjou F, Antwerpen PV, Duez P. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae). J Ethnopharmacol. 2014; 154: 361-69.

Benzekri R, Bouslama L, Papetti A, Hammami M, Smaoui A, Limam F. Anti HSV-2 activity of Peganum harmala (L.) and isolation of the active compound. Microb Pathogenesis. 2018; 114: 291-98.

Benzekri R, Limam F, Bouslama L. Combination effect of three anti‑HSV‑2 active plant extracts exhibiting different modes of action. Adv Tradit Med. 2020; 20; 223-31.

Berdai MA, Labib S, Harandou M. Peganum harmala L. intoxication in a pregnant woman. Case Rep Emerg Med. 2014; 783236.

Berrougui H, Isabelle M, Cloutier M, Hmamouchi M, Khalil A. Protective effects of Peganum harmala L. extract, harmine and harmaline against human low-density lipoprotein oxidation. J Pharm Pharmacol. 2006a; 58: 967-74.

Berrougui H, Martín-Cordero C, Khalil A, Hmamouchi M, Ettaib A, Marhuenda E, Herrera MD. Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seed's in isolated rat aorta. Pharmacol Res. 2006b; 54: 150-57.

Bhambhani S, Karwasara VS, Dixit VK, Banerjee S. Enhanced production of vasicine in Adhatoda vasica (L.) Nees. cell culture by elicitation. Acta Physiol Plant. 2012; 34: 1571-78.

Boeira JM, Viana AF, Picada JN, Henriques JAP. Genotoxic and recombinogenic activities of the two β-carboline alkaloids harman and harmine in Saccharomyces cerevisiae. Mutat Res. 2002; 500: 39-48.

Boonhok R, Sangkanu S, Chuprom J, Srisuphanunt M, Norouzi R, Siyadatpanah A, Mirzaei F, Mitsuwan W, Wisessombat S, Pereira ML, Rahmatullah M, Wilairatana P, Wiart C, Ling LC, Dolma KG, Nissapatorn V. Peganum harmala extract has antiamoebic activity to Acanthamoeba triangularis trophozoites and changes expression of autophagy-related genes. Pathogens 2021; 10: 842.

Bournine L, Bensalem S, Fatmi S, Bedjou F, Mathieu V, Iguer-Ouada M, Kiss R, Duez P. Evaluation of the cytotoxic and cytostatic activities of alkaloid extracts from different parts of Peganum harmala L. (Zygophyllaceae). Eur J Integr Med. 2017; 9: 91-96.

Bourogaa E, Jarraya RM, Damak M, Elfeki A. Hepatoprotective activity of Peganum harmala against ethanol-induced liver damages in rats. Arch Physiol Biochem. 2015; 121: 62-67.

Darabpour E, Bavi AP, Motamedi H, Nejad SMS. Antibacterial activity of different parts of Peganum harmala L. growing in Iran against multidrug resistant bacteria. EXCLI J. 2011; 10: 252-63.

Dastagir G, Hussain F, Rehman IU. Essential oil composition of some plants of Family Zygophyllaceae and Euphorbiaceae. Pakistan J Bot. 2014; 46: 2043-49.

Deng G, Wu C, Rong X, Li S, Ju Z, Wang Y, Ma C., Ding W, Guan H, Cheng X, Liu W, Wang C. Ameliorative effect of deoxyvasicine on scopolamine-induced cognitive dysfunction by restoration of cholinergic function in mice. Phytomedicine 2019; 63: 153007.

Diba K, Shoar MG, Shabatkhori M, Khorshivand Z. Antifungal activity of alcoholic extract of Peganum harmala seeds. J Med Plants Res. 2011; 5: 5550-54.

Di Giorgio, C, Delmas F, Ollivier E, Elias R, Balansard G, Timon-David P. In vitro activity of the β-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Exp Parasitol. 2004; 106: 67-74.

Edziri H, Marzouk B, Mabrouk H, Garreb M, Douki W, Mahjoub A, Verschaeve L, Najjar F, Mastouri M. Phytochemical screening, butyrylcholinesterase inhibitory activity and anti-inflammatory effect of some Tunisian medicinal plants. S Afr J Bot. 2018; 114: 84-88.

El-Dwairi QA, Banihani SM. Histofunctional effects of Peganum harmala on male rat's spermatogenesis and fertility. Neuroendocrinol Lett. 2007; 28: 305-10.

Elansary HO, Szopa A, Kubica P, Ekiert H, Al-Mana FA, El-Shafei AA. Polyphenols of Frangula alnus and Peganum harmala leaves and associated biological activities. Plants 2020; 9: 1086.

Fan Y, Zeng F, Ma L, Zhang H. Effects of β-carboline alkaloids from Peganum harmala on the FAK/PI3K/AKT/Mtor pathway in human gastric cancer cell line SGC-7901 and tumor-bearing mice. Pakistan J Pharm Sci. 2021; 34: 891-98.

Faridi P, Ghasemi Y, Mohagheghzadeh A. Chemical Composition of Peganum harmala smoke and volatile oil. J Essent Oil Bear Pl. 2013; 16: 850-54.

Farouk L, Laroubi A, Aboufatima R, Benharref A, Chait A. Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: Possible mechanisms involved. J Ethnopharmacol. 2008; 115: 449-54.

Faskhutdinov MF, Telezhenetskaya MV, Levkovich MG, Abdullaev ND. Alkaloids of Peganum harmala. Chem Nat Compd. 2000; 36: 602-05.

Filban F, Ravanbakhsh M, Poormohammadi A, Khaghani S, Sadeghi-Nejad B, Neisi A, Goudarzi G. Antimicrobial properties of Peganum harmala L. seeds’ smoke in indoors: Applications and prospects. Environ Monit Assess. 2022; 194: 1-13.

Frison G, Favretto D, Zancanaro F, Fazzin G, Ferrara SD. A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Sci Int. 2008; 179: e37-e43.

Ghizlane EA, Manal M, Ines HA, Soufiane D, Moussa L, Houssam B, Brahim H. Fatal poisoning of pregnant women by Peganum harmala L.: A case reports. Ann Med Surg. 2021; 68: 102649.

Guo X, Yuan J, Song X, Wang X, Sun Q, Tian J, Li X, Ding M, Liu Y. Bacteria metabolites from Peganum harmala L. polysaccharides inhibits polyQ aggregation through proteasome-mediated protein degradation in C. elegans. Int J Biol Macromol. 2020; 161: 681-91.

Hadadi Z, Nematzadeh GA, Ghahari S. A study on the anti-oxidant and antimicrobial activities in the chloroformic and methanolic extracts of 6 important medicinal plants collected from North of Iran. BMC Chem. 2020; 14: 33.

Hamden K, Carreau S, Ayadi F, Masmoudi H, Abdelfattah EL. Inhibitory effect of estrogens, phytoestrogens, and caloric restriction on oxidative stress and hepatotoxicity in aged rats. Biomed Environ Sci. 2009; 22: 381-87.

Hamden K, Masmoudi H, Ellouz F, ElFeki A, Carreau S. Protective effects of Peganum harmala extracts on thiourea-induced diseases in adult male rat. J Environ Biol. 2008; 29: 73-77.

Hamsa TP, Kuttan G. Harmine activates intrinsic and extrinsic pathways of apoptosis in B16F-10 melanoma. Chin Med-Uk. 2011a; 6: 1-8.

Hamsa TP, Kuttan G. Studies on anti-metastatic and anti-invasive effects of harmine using highly metastatic murine B16F-10 melanoma cells. J Environ Pathol Tox. 2011b; 30: 123-37.

Hayet E, Maha M, Mata M, Mighri Z, Laurent G, Mahjoub A. Biological activities of Peganum harmala leaves. Afr J Biotechnol. 2010; 9: 8199-205.

He D, Wu H, Wei Y, Liu W, Huang F, Shi H, Zhang B, Wu X, Wang C. Effects of harmine, an acetylcholinesterase inhibitor, on spatial learning and memory of APP/PS1 transgenic mice and scopolamine-induced memory impairment mice. Eur J Pharmacol. 2015; 768: 96-107.

Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H. β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol. 2010; 48: 839-45.

Herraiz T, Guillén F, Arán VJ, Salgado A. Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala. Food Chem Toxicol. 2017; 103: 261-69.

Herraiz T, Guillén H. Monoamine oxidase-A inhibition and associated antioxidant activity in plant extracts with poten-tial antidepressant actions. Biomed Res Int. 2018; 4810394.

Huang J, Liu Y, Chen JX, Lu XY, Zhu WJ, Qin L, Xun Z, Zheng Q, Li E, Sun N, Xu C, Chen HY. Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy. Acta Pharmacol Sin. 2022; 43: 50-63.

Im JH, Jin YR, Lee JJ, Yu JY, Han XH, Im SH, Hong JT, Yoo HS, Pyo MY, Yun YP. Antiplatelet activity of β-carboline alkaloids from Perganum harmala: A possible mechanism through inhibiting PLCγ2 phosphorylation. Vasc Pharmacol. 2009; 50: 147-52.

Iranshahy M, Bazzaz SF, Haririzadeh G, Abootorabi BZ, Mohamadi AM, Khashyarmanesh Z. Chemical composition and antibacterial properties of Peganum harmala L. Avicenna J Phytomed. 2019; 9: 530-37.

Jeppesen AS, Soelberg J, Jäger AK. Antibacterial and COX-1 inhibitory effect of medicinal plants from the Pamir Mountains, Afghanistan. Plants 2012; 1: 74-81.

Khadhr M, Bousta D, Hanane EH, Mansouri LE, Boukhira S, Lachkar M, Jamoussi B, Boukhchina S. HPLC and GC-MS analysis of Tunisian Peganum harmala seeds oil and evaluation of some biological activities. Am J Ther. 2016; 24: e706-e712.

Khadraoui N, Essid R, Jallouli S, Damergi B, Takfa IB, Abid G, Jedidi I, Bachali A, Ayed A, Limam F, Tabbene O. Antibacterial and antibioflm activity of Peganum harmala seed extract against multidrug‑resistant Pseudomonas aeruginosa pathogenic isolates and molecular mechanism of action. Arch Microbiol. 2022; 204: 133.

Khan AM, Abbas G, Qureshi RA, Khan U, Ghufran MA, Stoeckli-Evans H. 3-Hydroxy-1,2,3,9-tetrahydropyrrolo-[2,1-b]quinazolin-4-ium chloride dihydrate: (+)-Vasicinol hydrochloride dihydrate from Peganum harmala L. Acta Crystallogr. 2009; E65: o474-o475.

Khoshzaban F, Ghaffarifar F, Koohsari HRJ. Peganum harmala aqueous and ethanol extracts effects on lesions caused by Leishmania major (MRHO/IR/75/ER) in BALB/c mice. Jundishapur J Microb. 2014; 7: e10992.

Komeili G, Hashemi M, Bameri-Niafar M. Evaluation of antidiabetic and antihyperlipidemic effects of Peganum harmala seeds in diabetic rats. Cholesterol 2016; 7389864.

Lamchouri F, Zemzami M, Jossang A, Abdellatif A, Israili ZH, Lyoussi B. Cytotoxicity of alkaloids isolated from Peganum harmala seeds. Pakistan J Pharm Sci. 2013; 26: 699-706.

Lamounier AP, Mateus NS, da Cunha ALMC, Luna AS, Aucélio RQ. Determination of six β-carboline alkaloids in urine and phytotherapic extracts using micellar liquid chromatography with fluorimetric detection. J Liq Chromatogr Relat Technol. 2015; 38: 997-1006.

Le Moigne R, Subra F, Karam M, Auclair C. The β-carboline harmine induces actin dynamic remodeling and abrogates the malignant phenotype in tumorigenic cells. Cells. 2020; 9: 1168.

Li C, Wang Y, Wang C, Yi X, Li M, He X. Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells. Phytomedicine 2017; 28: 10-18.

Li SG, Wang KB, Gong C, Bao Y, Qin NB, Li DH, Li ZL, Bai J, Hua HM. Cytotoxic quinazoline alkaloids from the seeds of Peganum harmala. Bioorg Med Chem Lett. 2018a; 28: 103-06.

Li YP, He Q, Du SS, Guo SS, Geng ZF, Deng ZW. Study of methanol extracts from different parts of Peganum harmala L. using 1H-NMR plant metabolomics. J Anal Methods Chem. 2018b; 6532789.

Li HY, Wang Z, Wang YH, Xu JW, He XJ. Triterpenoids with antiproliferative effects from the seeds of Peganum harmala L. Phytochemistry 2020a; 174: 112342.

Li SG, Wang YT, Zhang Q, Wang KB, Xue JJ, Li DH, Jing YK, Lin B, Hua HM. Pegaharmols A-B, axially chiral β-carboline-quinazoline dimers from the roots of Peganum harmala. Org Lett. 2020b; 22: 7522-25.

Li Y, Li C, Wu J, Liu W, Li D, Xu J. Harmane ameliorates obesity though inhibiting lipid accumulation and inducing adipocyte browning. RSC adv. 2020c; 10: 4397-403.

Liu D, Zhang L, Duan LX, Wu JJ, Hu Mm Liu ZQ, Wang CY. Potential of herb-drug/herb interactions between substrates and inhibitors of UGTs derived from herbal medicines. Pharmacol Res. 2019; 150: 104510.

Liu J, Li Q, Liu Z, Lin L, Zhang X, Cao M, Jiang J. Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways. Oncol Rep. 2016; 35: 3363-70.

Liu L, Zhao T, Cheng XM, Wang CH, Wang ZT. Characterization and determination of trace alkaloids in seeds extracts from Peganum harmala Linn. using LC-ESI-MS and HPLC. Acta Chromatogr. 2013; 25: 221-40.

Liu X, Li M, Tan S, Wang C, Fan S, Huang C. Harmine is an inflammatory inhibitor through the suppression of NF-κB signaling. Biochem Bioph Res Co. 2017b; 489: 332-38.

Liu W, Cheng X, Wang Y, Li S, Zheng T, Gao Y, Wang G, Qi S, Wang J, Ni J, Wang Z, Wang C. In vivo evaluation of the antitussive, expectorant and bronchodilating effects of extract and fractions from aerial parts of Peganum harmala Linn. J Ethnopharmacol. 2015b; 162: 79-86.

Liu W, Wang Y, He DD, Li SP, Zhu YD, Jiang B, Cheng X, Wang Z, Wang CH. Antitussive, expectorant, and bronchodilating effects of quinazoline alkaloids (±)-vasicine, deoxyvasicine, and (±)-vasicinone from aerial parts of Peganum harmala L. Phytomedicine 2015a; 22: 1088-95.

Liu W, Zhu Y, Wang Y, Qi S, Wang Y, Ma C, Li S, Jiang B, Cheng X, Wang Z, Xuan Z, Wang C. Anti-amnesic effect of extract and alkaloid fraction from aerial parts of Peganum harmala on scopolamine-induced memory deficits in mice. J Ethnopharmacol. 2017b; 204: 95-106.

Ma X, Liu D, Tang H, Wang Y, Wu T, Li Y, Yang J, Yang JH, Sun SR, Zhang F. Purification and characterization of a novel antifungal protein with antiproliferation and anti-HIV-1 reverse transcriptase activities from Peganum harmala seeds. Acta Bioch Bioph Sin. 2013; 45: 87-94.

Madah M, Haddad S, Khazem M. Evaluation of the effect of Peganum harmala extracts on the in vitro viability of Leishmania tropica promastigotes in comparison to glucantime. J Parasit Dis. 2020; 44: 858-63.

Moradi MT, Karimi A, Fotouhi F, Kheiri S, Torabi A. In vitro and in vivo effects of Peganum harmala L. seeds extract against influenza A virus. Avicenna J Phytomed. 2017a; 7: 519-30.

Moradi MT, Karimi A, Rafieian-Kopaei M, Fotouhi F. In vitro antiviral effects of Peganum harmala seed extract and its total alkaloids against Influenza virus. Microb Pathogenesis. 2017b; 110: 42-49.

Moussa TAA, Almaghrabi OA. Fatty acid constituents of Peganum harmala plant using gas chromatography-mass spectroscopy. Saudi J Biol Sci. 2015; 23: 397-403.

Naresh G, Jaiswal N, Sukanya P, Srivastava AK, Tamrakar AK, Narender T. Glucose uptake stimulatory effect of 4-hydroxypipecolic acid by increased GLUT 4 translocation in skeletal muscle cells. Bioorg Med Chem Lett. 2012; 22: 5648-51.

Nasehi M, Piri M, Nouri M, Farzin D, Nayer-Nouri T, Zarrindast MR. Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test. Eur J Pharmacol. 2010; 634: 77-83.

Nenaah G. Antibacterial and antifungal activities of (beta)-carboline alkaloids of Peganum harmala (L) seeds and their combination effects. Fitoterapia 2010; 81: 779-82.

Nikam TD, Ebrahimi MA, Patil VA. Embryogenic callus culture of Tribulus terrestris L. a potential source of harmaline, harmine and diosgenin. Plant Biotechnol Rep. 2009; 3: 243-50.

Niroumand MC, Farzaei MH, Amin G. Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: A review. J Tradit Chin Med. 2015; 35: 104-09.

Niu X, Yao Q, Li W, Zang L, Li W, Zhao J, Liu F, Zhi W. Harmine mitigates LPS-induced acute kidney injury through inhibition of the TLR4-NF-κB/NLRP3 inflammasome signaling pathway in mice. Eur J Pharmacol. 2019; 849: 160-69.

Özkanlar S, Koc F, Karakuş E. The protective effects of Peganum harmala extract on lung and kidney in sepsis induced by cecal ligation and perforation in rats. Kafkas Univ Vet Fak. 2015; 21: 367-75.

Pitret S, Srivastavat SK. Two New Anthraquinones from the seeds of Peganum harmala. Planta Med. 1987; 53: 106-07.

Rahimi-Moghaddam P, Ebrahimi SA, Ourmazdi H, Selseleh M, Karjalian M, Haj-Hassani G, Alimohammadian MH, Mahmoudian M, Shafiei M. In vitro and in vivo activities of Peganum harmala extract against Leishmania major. J Res Med Sci. 2011; 16: 1032-39.

Rashidi M, Mahmoudian E, Mirzaei S, Mazloomi SN, Bazi A, Azadeh H, Mozaffari M. Harmaline down-regulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro. Chem-Biol Interact. 2022; 365: 110087.

Rezaei M, Nasri S, Roughani M, Niknami Z, Ziai SA. Peganum harmala L. extract reduces oxidative stress and improves symptoms in 6-hydroxydopamine-induced Parkinson’s disease in rats. IJPR. 2016; 15: 275-81.

Sadaf HM, Bibi Y, Arshad M, Razzaq A, Ahmad S, Iriti M, Qayyum A. Analysis of Peganum harmala, Melia azedarach and Morus alba extracts against six lethal human cancer cells and oxidative stress along with chemical characterization through advance fourier transform and nuclear magnetic resonance spectroscopic methods towards green chemotherapeutic agents. Saudi Pharm J. 2021; 29: 552-65.

Sadr Mohammadi R, Bidaki R, Mirdrikvand F, Mostafavi Yazdi SN, Yazdian Anari P. Peganum harmala (aspand) intoxication: A case report. Emergency 2016; 4: 106-07.

Saeidi S, Amini BN, Ahmadi H, Hassanshahian M. Antibac-terial activity of some plant extracts against extended-spectrum beta-lactamase producing Escherichia coli Isolates. Jundishapur J Microb. 2015; 8: e15434.

Saleh RA, Eissa TF, Abdallah DM, Saad MA, El-Abhar HS. Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model. Sci Rep-UK. 2021; 11(1): 1-14.

Selim SA, Aziz MHA, Mashait MS, Warrad MF. Antibacterial activities, chemical constitutes and acute toxicity of Egyptian Origanum majorana L., Peganum harmala L. and Salvia officinalis L. essential oils. Afr J Pharm Pharmaco. 2013; 7: 725-35.

Seyed Hassan Tehrani S, Hashemi Sheikh Shabani S, Tahmasebi Enferadi S, Rabiei Z. Growth inhibitory impact of Peganum harmala L. on two breast cancer cell lines. Iran J Biotechnol. 2014; 12: 8-14.

Shabani SHS, Tehrani SSH, Rabiei Z, Enferadi ST, Vannozzi GP. Peganum harmala L.’s anti-growth effect on a breast cancer cell line. Biotechnol Rep. 2015; 8: 138-43.

Sharaf M, El-Ansari MA, Matlin SA, Saleh NAM. Four flavonoid glycosides from Peganum harmala. Phytochemistry 1997; 44: 533-36.

Shen J, Wang B, Zhang T, Zhu N, Wang Z, Jin J, He Y, Hu M. Suppression of non-small cell lung cancer growth and metastasis by a novel small molecular activator of RECK. Cell Physiol Biochem. 2018; 45: 1807-17.

Shi CC, Chen SY, Wang GJ, Liao JF, Chen CF. Vasorelaxant effect of harman. Eur J Pharmacol. 2000; 390: 319-25.

Shoaib M, Shah SWA, Ali N, Shah I, Ullah S, Ghias M, Tahir MN, Gul F, Akhtar S, Ullah A, Akbar W, Ullah A. Scientific investigation of crude alkaloids from medicinal plants for the management of pain. Bmc Complem Altern M. 2016; 16: 1-8.

Shohaib HM, Nawaz S, Matin A. Methanolic extract of Peganum harmala exhibit potent activity against Acanthamoeba castellanii cysts and its encystment in vitro. Pakistan J Pharm Sci. 2016; 29: 1993-96.

Singh AB, Chaturvedi JP, Narender T, Srivastava AK. Preliminary studies on the hypoglycemic effect of Peganum harmala L. seeds ethanol extract on normal and streptozotocin induced diabetic rats. Indian J Clin Bioche. 2018; 23: 391-93.

Singh AB, Khaliq T, Chaturvedi JP, Narender T, Srivastava AK. Anti-diabetic and anti-oxidative effects of 4-hydroxy-pipecolic acid in C57BL/KsJ-db/db mice. Hum Exp Toxicol. 2012; 31: 57-65.

Singh VK, Mishra V, Tiwari S, Khaliq T, Barthwal MK, Pandey HP, Palit G, Narender T. Anti-secretory and cyto-protective effects of peganine hydrochloride isolated from the seeds of Peganum harmala on gastric ulcers. Phytomedicine 2013; 20: 1180-85.

Soliman AM, Abu-El-Zahab HS, Alswiai GA. Efficacy evaluation of the protein isolated from Peganum harmala seeds as an antioxidant in liver of rats. Asian Pac J Trop Med. 2013; 6: 285-95.

Tahraoui A, El-Hilaly J, Israili ZH, Lyoussi B. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province). J Ethnopharmacol. 2007; 110: 105-17.

Tahrouch S, Rapior S, Belahsen Y, Bessière JM, Andary C. Volatile constituents of Peganum harmala (Zygophyllaceae). Acta Bot Gallica. 1998; 145: 121-24.

Tascón M, Benavente F, Vizioli NM, Gagliardi LG. A rapid and simple method for the determination of psychoactive alkaloids by CE-UV: Application to Peganum harmala seed infusions. Drug Test Anal. 2017; 9: 596-602.

Waki H, Park KW, Mitro N, Pei L, Damoiseaux R, Wilpitz DC, Reue K, Saez E, Tontonoz P. The small molecule harmine is an anti-diabetic cell-type-specific regulator of PPARγ expression. Cell Metab. 2007; 5: 357-70.

Wang C, Zhang Z, Wang Y, He X. Cytotoxic constituents and mechanism from Peganum harmala. Chem Biodivers. 2016b; 13: 961-68.

Wang CH, Zeng H, Wang YH, Li C, Cheng J, Ye ZJ, He XJ. Antitumor quinazoline alkaloids from the seeds of Peganum harmala. J Asian Nat Prod Res. 2015a; 17: 595-600.

Wang CH, Zhang Z, Wang Y, He XJ. Cytotoxic indole alkaloids against human leukemia cell lines from the toxic plant Peganum harmala. Toxins. 2015b; 7: 4507-18.

Wang Y, Wang C, Jiang C, Zeng H, He X. Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells. Sci Rep-UK. 2015c; 5: 1-10.

Wang KB, Di YT, Bao Y, Yuan CM, Chen G, Li DH, Bai J, He HP, Hao XJ, Pei YH, Jing YK, Li ZL, Hua HM. Peganumine A, a β‑carboline dimer with a new octacyclic scaffold from Peganum harmala. Org Lett. 2014b; 16: 4028-31.

Wang KB, Li DH, Bao Y, Cao F, Wang WJ, Lin C, Bin W, Bai J, Pei YH, Jing YK, Yang DZ, Li ZL, Hua HM. Structurally diverse alkaloids from the seeds of Peganum harmala. J Nat Prod. 2017a; 80: 551-59.

Wang KB, Li DH, Hu P, Wang WJ, Lin C, Wang J, Lin B, Bai J, Pei YH, Jing YK, Li ZL, Yang DZ, Hua HM. A series of β-carboline alkaloids from the seeds of Peganum harmala show G-quadruplex interactions. Org Lett. 2016a; 18: 3398-401.

Wang KB, Li SG, Huang XY, Li DH, Li ZL, Hua HM. (±)‐Peharmaline A: A pair of rare β‐carboline-vasicinone hybrid alkaloid enantiomers from Peganum harmala. Eur J Org Chem. 2017b; 14: 1876-79.

Wang KB, Yuan CM, Xue CM, Li DH, Jing YK, He HP, Hao XJ, Di YT, Li ZL, Hua HM. Pegaharmalines A and B, two novel β-carboline alkaloids with unprecedented carbon skeletons from Peganum harmala. RSC Adv. 2014a; 4: 53725-29.

Wang KB, Hua X, Li SG, Li XY, Li DH, Bai J, Pei YH, Li ZL, Hu HM. Racemic indole alkaloids from the seeds of Peganum harmala. Fitoterapia 2018a; 125: 155-60.

Wang Y, Wang H, Zhang L, Zhang Y, Deng G, Li S, Cao N, Guan H, Cheng X, Wang C. Potential mechanisms of tremor tolerance induced in rats by the repeated administration of total alkaloid extracts from the seeds of Peganum harmala Linn. J Ethnopharmacol. 2020; 262: 113183.

Wang Y, Wang H, Zhang L, Zhang Y, Sheng Y, Deng G, Li S, Cao N, Guan H, Cheng X, Wang C. Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats. J Ethnopharmacol. 2019; 238: 111866.

Wang YX, Cao N, Guan HD, Cheng XM, Wang CH. Heme peroxidases are responsible for the dehydrogenation and oxidation metabolism of harmaline into harmine. Chin J Nat Med. 2022; 20: 194-201.

Wang ZY, Kang D, Jia X, Zhang HH, Guo JH, Liu CL, Meng QY, Liu WJ. Analysis of alkaloids from Peganum harmala L. sequential extracts by liquid chromatography coupled to ion mobility spectrometry. J Chromatogr B. 2018b; 1096: 73-79.

Wu C, Jiang XL, Shen HW, Yu AM. Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model. Biochem Pharmacol. 2009; 78: 617-24.

Wu ZN, Chen NH, Tang Q, Chen S, Zhan ZC, Zhang YB, Wang GC, Li YL, Ye WC. β-Carboline alkaloids from the seeds of Peganum harmala and their anti-HSV-2 virus activities. Org Lett. 2020; 22: 7310-14.

Yang YD, Cheng XM, Liu W, Chou GX, Wang ZT, Wang CH. Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation. J Ethnopharmacol. 2015; 168: 279-86.

Yang YD, Cheng XM, Liu W, Han ZZ, Chou GX, Wang Y, Sun DX, Wang ZT, Wang CH. Peganumine B-I and two enantiomers, new alkaloids from the seeds of Peganum harmala Linn and its potential cytotoxicity and cholinesterases inhibitory activities. RSC Adv. 2016; 6: 15976-87.

Yang Y, Ma Q, Li Z, Wang H, Zhang C, Liu Y, Li B, Wang Y, Cui Q, Xue F, Ai D, Zhu Y, He J. Harmine alleviates atherogenesis by inhibiting disturbed flow‐mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP. Brit J Pharmacol. 2021; 178: 1524-40.

Yavari N, Emamian F, Yarani R, Reza Mohammadi-Motlagh H, Mansouri K, Mostafaie A. In vitro inhibition of angiogenesis by heat and low pH stable hydroalcoholic extract of Peganum harmala seeds via inhibition of cell proliferation and suppression of VEGF secretion. Pharm Biol. 2015; 53: 855-61.

Yousefi R, Ghaffarifar F, Asl AD. The effect of Alkanna tincturia and Peganum harmala extracts on Leishmania major (MRHO/IR/75/ER) in vitro. Iran J Parasitol. 2009; 4: 40-47.

Yuruktumen A, Karaduman S, Bengi F, Fowler J. Syrian rue tea: A recipe for disaster. Clin Toxicol. 2008; 46: 749-52.

Zhang Q, Zan YH, Yang HG, Yang MY, Liu FS, Li SG, Peng XH, Lin B, Li ZL, Li DH, Hua HM. Anti-tumor alkaloids from Peganum harmala. Phytochemistry. 2022; 197: 113107.

Zhang Y, Shi X, Xie X, Laster KV, Pang M, Liu K, Hwang J, Kim DJ. Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR. Phytother Res. 2021; 35: 6377-88.

Published

2022-11-19

How to Cite

Liu, C., J. Gao, and Y. Liang. “Phytochemistry, Pharmacology and Toxicology of Peganum Harmala”. Bangladesh Journal of Pharmacology, vol. 17, no. 4, Nov. 2022, pp. 124-40, doi:10.3329/bjp.v17i4.61326.

Issue

Section

Mini Review